Last reviewed · How we verify
NCT05856812: BOBUINCA
BOrrelia BUrgdorferi IN Children and Adolescents
trial in B. Burgdorferi Infection in 962 participants. Completed in 6 February 2024.
6 February 2024
Quick facts
| Lead sponsor | University Children's Hospital Basel |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 962 |
| Start date | 23 June 2023 |
| Primary completion | 6 February 2024 |
| Estimated completion | 6 February 2024 |
| Sites | 1 location across Switzerland |
Conditions studied
- B. Burgdorferi Infection — all drugs for B. Burgdorferi Infection →
Sponsor
University Children's Hospital Basel
Who can join
Adults 1 to 17, any sex, with B. Burgdorferi Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess B. burgdorferi antibodies in children and adolescents in north-western Switzerland and neighbouring countries ("Triregio") treated at the University Children's Hospital Basel to define age-dependent B. burgdorferi seroprevalence rates.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05856812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Children's Hospital Basel trials
Trials by the same sponsor.
- NCT06861530 — A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymp · recruiting
- NCT05477810 — Bioequivalence of a Single-dose of 12 mg IVERMECTIN as Orally Disintegrating Mini Tablets Versus a Single-dose of 12 mg · EARLY_PHASE1 · completed
- NCT04812483 — Immunomodulation With Eltrombopag in ITP · Phase 2 · completed
- NCT05274334 — Measurement of Lipogenic Flux by Deuterium Resolved Mass Spectrometry Via Non-invasive Breath Analysis · NA · completed
- NCT04956718 — Breath Metabolomics of Placebo Effects, a Pilot Study · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05856812 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Children's Hospital Basel
- Last refreshed: 26 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05856812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing